Investing Profile

Jason Ruth

InvestorVC
Partner, MRL Ventures Fund at Merck
5amventures.comCambridge, Massachusetts
Photo of Jason Ruth, Partner at M Ventures (Merck)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
various Network
444 CONNECTIONS
various Network
444 CONNECTIONS
Merck Network
62 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
€600M
CompanyStageDateRound SizeTotal Raised
Aktis Oncology
Series BSep 2024$180M
Series AAug 2022$84M
$330M
Co-investors: Andrew Levin (RA Capital Management), Todd Foley (MPM BioImpact)
Carpenter's apprentice variousPresent
Carpenter's apprentice HotmailPresent
Board Observer variousPresent
Board Observer HotmailPresent
Carpenter's apprentice Homology Medicines, Inc.Present
UCLEADS Research Scholar and Research Technician Beckman Laser InstitutePresent
PhD in Bioengineering Penn Medicine Co-Investment ProgramPresent
Postdoctoral Research Fellow Dana-Farber Cancer InstitutePresent
Postdoctoral Research Fellow Broad Institute of MIT and HarvardPresent
Associate 5AM VenturesPresent
Board Observer Homology Medicines, Inc.Present
Board Observer Entrada TherapeuticsPresent
Board Observer Expansion TherapeuticsPresent
Board Observer Cabaletta BioPresent
Senior Associate 5AM VenturesPresent
Board Observer Vor BioPresent
Principal 5AM VenturesPresent
Sector Lead, Biotech Private Investments Wellington ManagementPresent
Partner, MRL Ventures Fund MerckPresent
UC Irvine BS Biomedical Engineering, UCLEADS Scholar
University of California, Irvine BS Biomedical Engineering, UCLEADS Scholar
University of Pennsylvania School of Medicine PhD Bioengineering, HHMI-NIBIB Scholar
Sign in with Google →
Sign in with Google →